织梦CMS - 轻松建站从此开始!

欧博ABG官网-欧博官方网址-会员登入

FDA approves weight loss drug Wegovy DG游戏to lower

时间:2025-10-20 03:30来源: 作者:admin 点击: 0 次
On March 8, the FDA approved the use of Wegovy to reduce the risk of cardiovascular death, heart attack, and stroke in adults with heart disease with

Other health benefits for semaglutide

Doctors also agree that as research continues, we may continue to see more and more uses for semaglutide as time goes on.

For example, a recent study found that semaglutide under the brand name Ozempic may help reduce kidney disease progression.

Other studies are currently evaluating the use of semaglutide in treating conditions such as:

“I think so because it’s a hormone and hormones have a wide range of effects throughout the body,” Dr. Ali commented. “As people focus on different areas, we may see more research on different effects.”

Dr. Saybolt noted anything that positively impacts a person’s weight, such as inflammation, blood sugar, blood pressure, and cholesterol, “could have a positive impact on just about any organ in the human body.”

“This stamp of approval from the FDA continues to support what the medical community has known all along — GLP-1s are here to treat serious chronic diseases, now cardiovascular disease in addition to diabetes and obesity. The research backing its use for other diseases, such as kidney disease (and) mental health addiction, to name a few, is extremely promising, I definitely foresee the FDA to continue to approve GLP-1s for use to combat other issues.”

— Dr. Angela Fitch, president of the Obesity Medicine Association

(责任编辑:)
------分隔线----------------------------
发表评论
请自觉遵守互联网相关的政策法规,严禁发布色情、暴力、反动的言论。
评价:
表情:
用户名: 验证码:
发布者资料
查看详细资料 发送留言 加为好友 用户等级: 注册时间:2025-10-20 09:10 最后登录:2025-10-20 09:10
栏目列表
推荐内容